Investigates herbal extract effects on kidney function in diabetic rat model, suggesting therapeutic potential.
Objectives: The present study investigated the therapeutic effects of a standardized capsule combination consisting of Channa striata, Phyllanthus niruri L., and Curcuma xanthorrhiza extracts (CCE) on biomarkers of kidney function, antioxidant status, and kidney histopathology in a high-fat diet (HFD) and alloxan-induced diabetic/nephrotoxic rat model. Materials and Methods: Male Wistar rats (n = 24) were divided into 4 groups: Control; HFD + alloxan treatment (diabetics/nephrotoxic); diabetics/nephrotoxic + CCE (49.5 mg/kg BW); diabetic/nephrotoxic + CCE + pioglitazone treatment group (1.35 mg/kg BW). Serum Cystatin C, superoxide dismutase (SOD) activity, and kidney histopathology were assessed at Day 60. Results: Model induction markedly increased blood glucose, HbA1c, and serum Cystatin C levels and decreased SOD activity (p < 0.001 vs controls). CCE significantly attenuated cystatin C by decreasing Cystatin C by 18.2% (p < 0.001) and restored SOD activity to 94.0% of control (p < 0.001). Histopathology showed marked improvements in glomerular hypertrophy, tubular injury, vascular congestion, and inflammatory infiltration (p < 0.001 vs model). CCE + pioglitazone showed comparable biochemical trends and enhanced histological preservation. Conclusions: CCE combination significantly attenuated diabetic/nephrotoxic-induced kidney injury by improving antioxidant defense and preserving kidney structure. This suggests therapeutic potential for managing metabolic kidney complications.
No takes yet. Share an insight, caveat, or question.
Yulizal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: